Wiki Page, Test Course: Week 8: Schizophrenia as a psychiatric disease/Neuroethics and the changing of identity

Wiki Page
2014-06-30T22:46:01-06:00

Schizophrenia as a psychiatric disease Prof Max Bennett. The neurophysiological determinates underlying the lack of capacity to control one’s actions, using the case study of McNaughton’s Rules.

Sumner P, Husain M. (2008) At the edge of consciousness: automatic motor activation and voluntary control. Neuroscientist. 2008 14(5):474-86. Epub 2008 Mar 20. Review.

Neuroethics and the changing of identity Scott Fitzpatrick. Advances in neuroscience and biotechnology have led to the development of medical technologies capable of enhancing our mental abilities. This has led to concerns that psychopharmaceuticals are being used by persons for “cosmetic” purposes, thus raising important ethical questions about our experiences in the world, as well as notions of authenticity and identity. This lecture will explore some of the central points on which ethical debates about “cosmetic psychopharmacology” hinge.

Elliott, C. (2004). Introduction. In C. Elliott & T. Chambers (Eds.), Prozac as a way of life (pp. 1-18). Chapel Hill & London: The University of North Carolina Press.

Cerullo, M. A. (2006). Cosmetic psychopharmacology and the President's Council on Bioethics. Perspectives in biology and medicine 49(4): 515-523